757 related articles for article (PubMed ID: 10353815)
1. Crystal structure of NAD(P)H:flavin oxidoreductase from Escherichia coli.
Ingelman M; Ramaswamy S; Nivière V; Fontecave M; Eklund H
Biochemistry; 1999 Jun; 38(22):7040-9. PubMed ID: 10353815
[TBL] [Abstract][Full Text] [Related]
2. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.
Gruez A; Pignol D; Zeghouf M; Covès J; Fontecave M; Ferrer JL; Fontecilla-Camps JC
J Mol Biol; 2000 May; 299(1):199-212. PubMed ID: 10860732
[TBL] [Abstract][Full Text] [Related]
3. Reaction of the NAD(P)H:flavin oxidoreductase from Escherichia coli with NADPH and riboflavin: identification of intermediates.
Nivière V; Vanoni MA; Zanetti G; Fontecave M
Biochemistry; 1998 Aug; 37(34):11879-87. PubMed ID: 9718311
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the flavin reductase component (HpaC) of 4-hydroxyphenylacetate 3-monooxygenase from Thermus thermophilus HB8: Structural basis for the flavin affinity.
Kim SH; Hisano T; Iwasaki W; Ebihara A; Miki K
Proteins; 2008 Feb; 70(3):718-30. PubMed ID: 17729270
[TBL] [Abstract][Full Text] [Related]
5. The three-dimensional structure of flavodoxin reductase from Escherichia coli at 1.7 A resolution.
Ingelman M; Bianchi V; Eklund H
J Mol Biol; 1997 Apr; 268(1):147-57. PubMed ID: 9149148
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
Waksman G; Krishna TS; Williams CH; Kuriyan J
J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of putidaredoxin reductase from Pseudomonas putida, the final structural component of the cytochrome P450cam monooxygenase.
Sevrioukova IF; Li H; Poulos TL
J Mol Biol; 2004 Feb; 336(4):889-902. PubMed ID: 15095867
[TBL] [Abstract][Full Text] [Related]
8. Atomic structure of ferredoxin-NADP+ reductase: prototype for a structurally novel flavoenzyme family.
Karplus PA; Daniels MJ; Herriott JR
Science; 1991 Jan; 251(4989):60-6. PubMed ID: 1986412
[TBL] [Abstract][Full Text] [Related]
9. Flavin reductase P: structure of a dimeric enzyme that reduces flavin.
Tanner JJ; Lei B; Tu SC; Krause KL
Biochemistry; 1996 Oct; 35(42):13531-9. PubMed ID: 8885832
[TBL] [Abstract][Full Text] [Related]
10. X-ray structure of the ferredoxin:NADP+ reductase from the cyanobacterium Anabaena PCC 7119 at 1.8 A resolution, and crystallographic studies of NADP+ binding at 2.25 A resolution.
Serre L; Vellieux FM; Medina M; Gomez-Moreno C; Fontecilla-Camps JC; Frey M
J Mol Biol; 1996 Oct; 263(1):20-39. PubMed ID: 8890910
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of a ferredoxin reductase for the CYP199A2 system from Rhodopseudomonas palustris.
Xu F; Bell SG; Peng Y; Johnson EO; Bartlam M; Rao Z; Wong LL
Proteins; 2009 Dec; 77(4):867-80. PubMed ID: 19626710
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of the short-chain flavin reductase HpaC from Sulfolobus tokodaii strain 7 in its three states: NAD(P)(+)(-)free, NAD(+)(-)bound, and NADP(+)(-)bound.
Okai M; Kudo N; Lee WC; Kamo M; Nagata K; Tanokura M
Biochemistry; 2006 Apr; 45(16):5103-10. PubMed ID: 16618099
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of coenzyme binding to human methionine synthase reductase revealed through the crystal structure of the FNR-like module and isothermal titration calorimetry.
Wolthers KR; Lou X; Toogood HS; Leys D; Scrutton NS
Biochemistry; 2007 Oct; 46(42):11833-44. PubMed ID: 17892308
[TBL] [Abstract][Full Text] [Related]
14. Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA.
McLean KJ; Scrutton NS; Munro AW
Biochem J; 2003 Jun; 372(Pt 2):317-27. PubMed ID: 12614197
[TBL] [Abstract][Full Text] [Related]
15. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
16. The flavoprotein component of the Escherichia coli sulfite reductase: expression, purification, and spectral and catalytic properties of a monomeric form containing both the flavin adenine dinucleotide and the flavin mononucleotide cofactors.
Zeghouf M; Fontecave M; Macherel D; Covès J
Biochemistry; 1998 Apr; 37(17):6114-23. PubMed ID: 9558350
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of NADH-dependent ferredoxin reductase component in biphenyl dioxygenase.
Senda T; Yamada T; Sakurai N; Kubota M; Nishizaki T; Masai E; Fukuda M; Mitsuidagger Y
J Mol Biol; 2000 Dec; 304(3):397-410. PubMed ID: 11090282
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of NADPH:ferredoxin reductase from Azotobacter vinelandii.
Sridhar Prasad G; Kresge N; Muhlberg AB; Shaw A; Jung YS; Burgess BK; Stout CD
Protein Sci; 1998 Dec; 7(12):2541-9. PubMed ID: 9865948
[TBL] [Abstract][Full Text] [Related]
19. Potentiometric and further kinetic characterization of the flavin-binding domain of Saccharomyces cerevisiae flavocytochrome b2. Inhibition by anions binding in the active site.
Cénas N; Lê KH; Terrier M; Lederer F
Biochemistry; 2007 Apr; 46(15):4661-70. PubMed ID: 17373777
[TBL] [Abstract][Full Text] [Related]
20. Crystallization and preliminary X-ray diffraction studies of human cytochrome P450 reductase.
Zhao Q; Smith G; Modi S; Paine M; Wolf RC; Tew D; Lian LY; Primrose WU; Roberts GC; Driessen HP
J Struct Biol; 1996; 116(2):320-5. PubMed ID: 8812989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
